Cell Receptor Inc. has IP for improving results in oncological treatment by targeting upstream steps of growth signaling, not noticed in oncology yet. A well-tolerated affordable treatment of low toxicity! It will prevent metastasis in most cancers.
Products, services, technology
Growing cells, including tumor cells, need to bind with platelets to grow. Platelets provide the cells with growth factors, help cells evade the immune system, and protect circulating tumor cells against shear stress. We know how to block this contact using inexpensive and well-tolerated substances.
Cooperation possibilities
We are looking for funding of our already designed proof-of-concept study and for partnerships in optimizing small molecules interfering with extracellular growth signaling.
- http://www.cellreceptor.ch
- +49 16 04 86 32 14
- hafabricius@cellreceptor.ch
- Hans-Åke Sven Fabricius
